APA (7th ed.) Citation

XL, S., YY, Z., YJ, L., HL, G., Y, L., XP, L., . . . F, C. (2026). Defining the Therapeutic Range of Levetiracetam for Personalized Treatment in Pediatric Epilepsy: Insights from a Large Real-World Study. Drug design, development and therapy, 20, 593587. https://doi.org/10.2147/DDDT.S593587

Chicago Style (17th ed.) Citation

XL, Sun, Zhang YY, Liu YJ, Guo HL, Li Y, Lu XP, Wu CF, Liang C, and Chen F. "Defining the Therapeutic Range of Levetiracetam for Personalized Treatment in Pediatric Epilepsy: Insights from a Large Real-World Study." Drug Design, Development and Therapy 20 (2026): 593587. https://doi.org/10.2147/DDDT.S593587.

MLA (9th ed.) Citation

XL, Sun, et al. "Defining the Therapeutic Range of Levetiracetam for Personalized Treatment in Pediatric Epilepsy: Insights from a Large Real-World Study." Drug Design, Development and Therapy, vol. 20, 2026, p. 593587, https://doi.org/10.2147/DDDT.S593587.